Semi-Annual Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7566829

Concept 2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
Semi-annual consolidated statement of income
Statement of income
Net sales
92,979,000,000 JPY
128,330,000,000 JPY
90,585,000,000 JPY
120,193,000,000 JPY
Cost of sales
42,046,000,000 JPY
55,630,000,000 JPY
37,893,000,000 JPY
50,126,000,000 JPY
Gross profit (loss)
50,933,000,000 JPY
72,699,000,000 JPY
52,692,000,000 JPY
70,067,000,000 JPY
Ordinary profit (loss)
14,057,000,000 JPY
16,051,000,000 JPY
10,608,000,000 JPY
12,638,000,000 JPY
Extraordinary income
453,000,000 JPY
453,000,000 JPY
660,000,000 JPY
660,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
12,209,000,000 JPY
11,481,000,000 JPY
Salaries
4,744,000,000 JPY
4,896,000,000 JPY
Bonuses
1,346,000,000 JPY
1,257,000,000 JPY
Taxes and dues
446,000,000 JPY
453,000,000 JPY
Depreciation
409,000,000 JPY
457,000,000 JPY
Selling, general and administrative expenses
40,083,000,000 JPY
61,099,000,000 JPY
44,077,000,000 JPY
60,730,000,000 JPY
Extraordinary losses
351,000,000 JPY
391,000,000 JPY
1,331,000,000 JPY
342,000,000 JPY
Profit (loss) before income taxes
14,159,000,000 JPY
16,113,000,000 JPY
9,936,000,000 JPY
12,956,000,000 JPY
Operating profit (loss)
10,850,000,000 JPY
11,599,000,000 JPY
8,615,000,000 JPY
9,337,000,000 JPY
Non-operating income
Interest income
80,000,000 JPY
894,000,000 JPY
57,000,000 JPY
153,000,000 JPY
Dividend income
1,219,000,000 JPY
978,000,000 JPY
1,328,000,000 JPY
905,000,000 JPY
Share of profit of entities accounted for using equity method
424,000,000 JPY
569,000,000 JPY
Non-operating income
3,235,000,000 JPY
4,791,000,000 JPY
2,531,000,000 JPY
3,453,000,000 JPY
Income taxes - current
3,525,000,000 JPY
4,419,000,000 JPY
3,394,000,000 JPY
3,727,000,000 JPY
Income taxes - deferred
219,000,000 JPY
-432,000,000 JPY
-627,000,000 JPY
-633,000,000 JPY
Non-operating expenses
Interest expenses
15,000,000 JPY
20,000,000 JPY
Non-operating expenses
27,000,000 JPY
340,000,000 JPY
538,000,000 JPY
152,000,000 JPY
Income taxes
3,745,000,000 JPY
3,987,000,000 JPY
2,767,000,000 JPY
3,093,000,000 JPY
Profit (loss)
10,414,000,000 JPY
10,414,000,000 JPY
10,414,000,000 JPY
12,126,000,000 JPY
10,414,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
9,862,000,000 JPY
7,169,000,000 JPY
Extraordinary income
Profit (loss) attributable to non-controlling interests
383,000,000 JPY
204,000,000 JPY
Extraordinary losses
Profit (loss) attributable to owners of parent
11,742,000,000 JPY
11,742,000,000 JPY
11,742,000,000 JPY
9,658,000,000 JPY
9,658,000,000 JPY
9,658,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,991,000,000 JPY
-1,065,000,000 JPY
Foreign currency translation adjustment
10,188,000,000 JPY
6,761,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-456,000,000 JPY
475,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-5,000,000 JPY
-7,000,000 JPY
Other comprehensive income
11,718,000,000 JPY
6,020,000,000 JPY
Comprehensive income
23,844,000,000 JPY
15,883,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
23,458,000,000 JPY
15,724,000,000 JPY
Comprehensive income attributable to non-controlling interests
386,000,000 JPY
158,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.